← All trials
NCT05532072
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2022
- Primary completion
- Sep 30, 2023
- Completion date
- Sep 30, 2023
- First posted
- Sep 8, 2022
- Last posted
- Sep 8, 2022
- Enrollment
- 140
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Jiao Tong UniversityLead sponsor
- Capital Medical UniversityCollaborator
- Shandong UniversityCollaborator
- Jiao Tong UniversityOfficial
- Jiangsu UniversityCollaborator
- Nanjing Medical UniversityCollaborator
- Xinjiang Medical UniversityCollaborator
- Southern Medical UniversityCollaborator
- Air Force Military Medical University, ChinaCollaborator
- Zhejiang UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.